Osteoarthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People (male or female) who have lost part of their outer knee cartilage pad (lateral meniscus) and have pain on the outer side of the knee joint, OR who have lost part of their inner knee cartilage pad (medial meniscus) and have pain on the inner side of the knee joint
- People whose remaining rim of the cartilage pad is strong enough to support the procedure
- People aged between 18 and 60 years
- People who have signed a written consent form agreeing to take part and to have their data used in anonymous form for research
Who may not be able to join:
- People with an unstable or torn ACL (the main stabilising ligament in the knee) that has not been repaired by surgery within 16 weeks of any cartilage pad procedure
- People whose legs are significantly out of alignment (more than 2 degrees bowed inward or outward)
- People who need a bone realignment surgery that has not been done within 12 weeks (confirm with trial site)
- People with serious cartilage damage or significant arthritis in the affected part of the knee, based on specific medical grading scales
- People who cannot fully straighten their knee (more than 3 degrees difference compared to the other leg), or who cannot bend the knee to at least 125 degrees
- People with inflammatory arthritis or joint inflammation in the knee being treated
- People with a BMI (body mass index) above 30
- People under 18 or over 60 years of age
- People who experience ongoing long-term chronic pain conditions
- People scheduled for surgery who have an increased risk during anaesthesia (such as a known or predicted difficult airway), an increased risk of bleeding, an increased risk of infection, poorly supplied or damaged tissue at the treatment site, a history of allergic reactions, a known or suspected allergy to the trial treatment or its ingredients, or who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sven Behrendt, MD, Privatpraxis für Knie- und Schulterchirurgie
Phone: +49231 8626064
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate efficacy of the procedure; Improvement of International Knee Documentation Committee (IKDC) score (between 0 and 100, the higher the better); Improvement of Knee Injury and Osteoarthritis Outcome Score (KOOS) score (between 0 and 100, the higher the better); Improvement of Visual Analogue Scale (VAS) Pain Score (between 0 and 10, the lower the better)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.